Recent News
COCP: Cocrystal Pharma Presents Phase 1 Results for Pan-Viral Inhibitor CDI-988 At DOD Medical Conference Including That All Cdi-988 Doses, Ranging From 100 Mg To 1200 Mg In Phase 1 Study Were Well Tolerated& Company Expects To Initiate Phase 1b Study With Cdi-988 In Norovirus-infected Healthy Subjects Later This Year
COCP: Cocrystal Pharma Reports Phase 1 Results With Oral, Broad-Acting Antiviral Drug CDI-988 For Prophylaxis And Treatment Of Norovirus, Coronaviruses And Other Viral Infections; Data Show Favorable Safety And Tolerability With Dosing Up To 800 mg For 10 Days; Plans To Initiate Human Challenge Study In 2025 In Norovirus-infected Subjects
What you need to know
Coronavirus News
Coronavirus Good News
Today's Coronavirus Good News Story of the day
Coronavirus: Formula 1 teams are to help in supply of ventilators
From The BBC: Formula 1 teams are working with government and health authorities to increase the supply of ventilators during the coronavirus crisis. Ventilators are a device used to help supply more air to patients with breathing difficulties, one of the effects of severe coronavirus symptoms.